Clinical trial NCT01754662 - References

Type 2 Diabetes — Effects of Combining Cocoa and Soy in Type 2 Diabetes

Citation(s)

•   Anderson JW, Smith BM, Washnock CS
  Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr. 1999 Sep;70(3 Suppl):464S-474S. doi: 10.1093/ajcn/70.3.464s. Review.
•   Chedraui P, San Miguel G, Hidalgo L, Morocho N, Ross S
  Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index. Gynecol Endocrinol. 2008 Nov;24(11):620-4. doi: 10.1080/09513590802288283.
•   Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS
  Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab. 1999 Oct;84(10):3479-84. Erratum in: J Clin Endocrinol Metab 2000 Jan;85(1):448.
•   Goodman-Gruen D, Kritz-Silverstein D
  Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr. 2001 Apr;131(4):1202-6.
•   Hermansen K, Søndergaard M, Høie L, Carstensen M, Brock B
  Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 2001 Feb;24(2):228-33.
•   Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL
  Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002 Oct;25(10):1709-14.
•   Konya J, Sathyapalan T, Kilpatrick ES, Atkin SL
  The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study. Front Endocrinol (Lausanne). 2019 May 9;10:296. doi: 10.3389/fendo.2019.00296. eCollection 2019.
•   Lee DS, Lee SH
  Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. FEBS Lett. 2001 Jul 13;501(1):84-6.
•   Scholey AB, French SJ, Morris PJ, Kennedy DO, Milne AL, Haskell CF
  Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol. 2010 Oct;24(10):1505-14. doi: 10.1177/0269881109106923. Epub 2009 Nov 26.
•   Sorenson RL, Brelje TC, Roth C
  Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology. 1994 Apr;134(4):1975-8.
•   Tsai AC, Vinik AI, Lasichak A, Lo GS
  Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Am J Clin Nutr. 1987 Mar;45(3):596-601.
•   Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H
  Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res. 1999 Nov;13(7):601-8.
•   Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB
  Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism. 1997 Jun;46(6):698-705.

A Pilot Study Investigating the Effects of the Combined Effects of Cocoa and Soy Polyphenols in a Soy Protein Matrix on Insulin Resistance and Cardiovascular Disease Risk in Type 2 Diabetes - A Randomised Placebo-Controlled Double-Blind Parallel Study

Details for clinical trial NCT01754662